Motor-cortical oscillations in early stages of Parkinson's disease

University of Düsseldorf, Medical Faculty, Institute of Clinical Neuroscience and Medical Psychology, Department of Neurology, Düsseldorf, Germany.
The Journal of Physiology (Impact Factor: 4.54). 04/2012; 590(Pt 13):3203-12. DOI: 10.1113/jphysiol.2012.231316
Source: PubMed

ABSTRACT Pathophysiological changes in basal ganglia-thalamo-cortical circuits are well established in idiopathic Parkinson's disease (PD). However, it remains open whether such alterations already occur at early stages representing a characteristic neurophysiological marker of PD. Therefore, the present study aims at elucidating changes of synchronised oscillatory activity in early PD patients. In this study, we performed whole-head magnetoencephalography (MEG) in a resting condition and during steady state contraction of the more severely affected forearm in 10 drug–naive, de novo patients, in 10 early-stage patients with chronic medication and in 10 age-matched control subjects. While cortico-muscular coherence (CMC) did not differ between groups, patients showed increased sensori-motor cortical power at beta frequency (13–30 Hz) during rest as well as during isometric contraction compared to controls. In healthy control subjects the power of the contralateral hemisphere was significantly suppressed during isometric contraction. By contrast, both hemispheres were activated equally strongly in de novo patients. In medicated patients, the pattern was found to be reversed. Contralateral beta power was significantly correlated with motor impairment during isometric contraction but not during rest. The present results suggest that the reduced ability of the primary motor cortex to disengage from increased beta band oscillations during the execution of movements is an early marker of PD.

Download full-text


Available from: Bettina Pollok, Sep 12, 2014
1 Follower
  • Source
    • "activity in the sensorimotor cortex (SMC) is coherent with electromyographic (EMG) activity of the contralateral muscle in the b-band (15–30 Hz) during isometric contraction (Conway et al., 1995; Salenius et al., 1997; Gross et al., 2000; Pohja et al., 2005; Kristeva-Feige et al., 2002; Ushiyama et al., 2010, 2011a,b; Omlor et al., 2007, 2011; Johnson et al., 2011; Perez et al., 2012; Divekar and John, 2013; Mendez-Balbuena et al., 2012; Patino et al., 2008; Pollok et al., 2012). These oscillatory interactions between the cortex and muscle can be assessed by calculation of coherence, which is a measure of linear correlation in the frequency domain. "
    [Show abstract] [Hide abstract]
    ABSTRACT: β-Band corticomuscular coherence is suggested as an electrophysiological mechanism that contributes to sensorimotor functioning in the maintenance of steady-state contractions. Converging evidence suggests that not only the descending corticospinal pathway but the ascending sensory feedback pathway is involved in the generation of β-band corticomuscular coherence. The present study aimed to investigate which pathway, descending vs. ascending, contributes more to the stability of muscle contraction, especially for human intrinsic hand muscles.
    Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology 10/2014; 125(10). DOI:10.1016/j.clinph.2014.02.006 · 2.98 Impact Factor
  • Source
    • "This may be due to the fact that the majority of studies focus on late-stage patients who are usually taking dopamine replacement therapies which are known to reduce beta power (Silberstein et al., 2005; Kuhn et al., 2006; Ku¨hn et al., 2009; Jenkinson and Brown, 2011) or collapse of cortical beta generation in later stages of the disease. The results presented here confirm those in a previous investigation in early-stage PD patients which did report enhanced beta in M1 contralateral to the most severely affected side (Pollok et al., 2012). Anecdotally, a number of the patients (e.g. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In Parkinson's disease (PD), elevated beta (15 - 35 Hz) power in subcortical motor networks is widely believed to promote aspects of PD symptomatology, moreover, a reduction in beta power and coherence accompanies symptomatic improvement following effective treatment with L-DOPA. Previous studies have reported symptomatic improvements that correlate with changes in cortical network activity following GABAA receptor modulation. In this study we have used whole-head magnetoencephalography to characterise neuronal network activity, at rest and during visually cued finger abductions, in unilaterally symptomatic PD and age-matched control participants. Recordings were then repeated following administration of sub-sedative doses of the hypnotic drug zolpidem (0.05 mg/Kg), which binds to the benzodiazepine site of the GABAA receptor. A beamforming based 'virtual electrode' approach was used to reconstruct oscillatory power in primary motor cortex, contralateral and ipsilateral to symptom presentation in PD patients or dominant hand in control participants. In PD patients, contralateral M1 showed significantly greater beta power than ipsilateral M1. Following zolpidem administration contralateral beta power was significantly reduced while ipsilateral beta power was significantly increased resulting in a hemispheric power ratio that approached parity. Furthermore, there was highly significant correlation between hemispheric beta power ratio and UPDRS. The changes in contralateral and ipsilateral beta power were reflected in pre-movement beta desynchronisation and the late post-movement beta rebound. However, the absolute level of movement-related beta desynchronisation was not altered. These results show that low-dose zolpidem not only reduces contralateral beta but also increases ipsilateral beta, whilst rebalancing the dynamic range of M1 network oscillations between the two hemispheres. These changes appear to underlie the symptomatic improvements afforded by low-dose zolpidem.
    Neuroscience 09/2014; 281. DOI:10.1016/j.neuroscience.2014.09.037 · 3.33 Impact Factor
  • Source
    • "In our study, CMC did not correlate with disease duration. Weak CMC is probably not a characteristic feature at the onset of PD as CMC of patients does not differ from that of controls in the early stages of the disease (Pollok et al., 2012). It is obvious on the basis of our data that STN DBS had a variable effect on CMC amplitude in patients with PD. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective Cortico-muscular coherence (CMC) is thought to reflect the interplay between cortex and muscle in motor coordination. In Parkinson’s disease (PD) patients, levodopa has been shown to enhance CMC. This study examined whether subthalamic nucleus (STN) deep brain stimulation (DBS) affects the CMC in advanced PD. Methods Magnetoencephalography (MEG) and electromyography (EMG) measurements were done simultaneously both with DBS on and off to determine the CMC during wrist extension. The spatiotemporal signal space separation (tSSS) was used for artifact suppression. Results CMC peaks between 13 and 25 Hz were found in 15 out of 19 patients. The effect of DBS on CMC was variable. Moreover, the correlation between CMC and motor performance was inconsistent; stronger CMC did not necessarily indicate better function albeit tremor and rigidity may diminish the CMC. Patients having CMC between 13 – 25 Hz had the best motor scores at the group level. Conclusions DBS modifies the CMC in advanced PD with large interindividual variability, with no linear correlation between CMC amplitude and motor symptoms. Significance DBS does not systematically modify CMC amplitude in advanced PD. The results suggest that some components of the CMC may be related to the therapeutic effects of DBS.
    Clinical Neurophysiology 08/2014; 126(4). DOI:10.1016/j.clinph.2014.07.025 · 2.98 Impact Factor
Show more